As low-dose prophylactic aspirin therapy becomes common among older people, potential risks that are associated with such treatment assume increasing importance. In particular, some clinicians are ...
Description The goal of the trial was to evaluate treatment with famotidine compared with placebo among patients taking low-dose aspirin. Hypothesis Famotidine would be more effective in ...
A recent population-based cohort study in Denmark has revealed a significant association between low-dose aspirin (LDA) use and the incidence of anaemia among older adults. Conducted from 2008 to 2013 ...
Low-Dose Aspirin may increase Risk of Anaemia in Older Adults suggests a study published in the European Heart Journal. A study was done to assess the risk of anaemia among low-dose aspirin (LDA) ...
In the 19th century, the active ingredient in willow bark, salicin, was identified, leading to the development of modern aspirin. Today, it is a key tool in preventing heart attacks and strokes. A ...